COURTNEY NAVARETTE: Open Payments
NPI 1376329383 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 20 payments from 8 companies in 2025. Trend: 2023 $77 · 2024 $966 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $92 |
| Neurocrine BioSciences, Inc. | 5 | $90 |
| Axsome Therapeutics, Inc. | 4 | $80 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
| ABBVIE INC. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Lundbeck LLC | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: CAPLYTA, INGREZZA, Auvelity, VRAYLAR, COBENFY, SPRAVATO, REXULTI, INVEGA SUSTENNA.
Industry payments across TX — which companies pay providers there.
